Search Page

1

Cite

Share

Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans.

Strayer DR, Dickey R, Carter WA. Strayer DR, et al. Infect Disord Drug Targets. 2014;14(1):37-43. doi: 10.2174/1871526514666140713152858. Infect Disord Drug Targets. 2014. PMID: 25019238 Review.

Cite

Share

2

Cite

Share

Recombinant and natural human interferons: analysis of the incidence and clinical impact of neutralizing antibodies.

Strayer DR, Carter WA. Strayer DR, et al. J Interferon Cytokine Res. 2012 Mar;32(3):95-102. doi: 10.1089/jir.2011.0069. Epub 2011 Dec 1. J Interferon Cytokine Res. 2012. PMID: 22132684 Review.

Cite

Share

3

Cite

Share

Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Strayer DR, Young D, Mitchell WM. Strayer DR, et al. PLoS One. 2020 Oct 29;15(10):e0240403. doi: 10.1371/journal.pone.0240403. eCollection 2020. PLoS One. 2020. PMID: 33119613 Free PMC article. Clinical Trial.

Cite

Share

4

Cite

Share

Specific RNA drug therapy of hepatitis viruses.

Carter WA, Suhadolnik RJ, Müller WE, Korba BE, Hubbell HR, Garcia G, Strayer DR. Carter WA, et al. Among authors: strayer dr. Ann N Y Acad Sci. 1993 Jun 23;685(1):758-61. doi: 10.1111/j.1749-6632.1993.tb35938.x. Ann N Y Acad Sci. 1993. PMID: 8363282 Free PMC article. Review. No abstract available.

Cite

Share

5

Cite

Share

Discordant biological and toxicological species responses to TLR3 activation.

Mitchell WM, Nicodemus CF, Carter WA, Horvath JC, Strayer DR. Mitchell WM, et al. Among authors: strayer dr. Am J Pathol. 2014 Apr;184(4):1062-1072. doi: 10.1016/j.ajpath.2013.12.006. Epub 2014 Jan 30. Am J Pathol. 2014. PMID: 24486326 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

Subclassifying chronic fatigue syndrome through exercise testing.

Vanness JM, Snell CR, Strayer DR, Dempsey L 4th, Stevens SR. Vanness JM, et al. Among authors: strayer dr. Med Sci Sports Exerc. 2003 Jun;35(6):908-13. doi: 10.1249/01.MSS.0000069510.58763.E8. Med Sci Sports Exerc. 2003. PMID: 12783037 Clinical Trial.

Cite

Share

7

Cite

Share

Protection from pulmonary tissue damage associated with infection of cynomolgus macaques by highly pathogenic avian influenza virus (H5N1) by low dose natural human IFN-α administered to the buccal mucosa.

Strayer DR, Carter WA, Stouch BC, Stittelaar KJ, Thoolen RJ, Osterhaus AD, Mitchell WM. Strayer DR, et al. Antiviral Res. 2014 Oct;110:175-80. doi: 10.1016/j.antiviral.2014.07.010. Epub 2014 Aug 9. Antiviral Res. 2014. PMID: 25111905 Free PMC article.

Cite

Share

8

Cite

Share

A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, Cimoch PJ, Lapp CW, Peterson DL; Chronic Fatigue Syndrome AMP-516 Study Group, Mitchell WM. Strayer DR, et al. PLoS One. 2012;7(3):e31334. doi: 10.1371/journal.pone.0031334. Epub 2012 Mar 14. PLoS One. 2012. PMID: 22431963 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Intranasal administration of adjuvant-combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus.

Ichinohe T, Ainai A, Ami Y, Nagata N, Iwata N, Kawaguchi A, Suzaki Y, Odagiri T, Tashiro M, Takahashi H, Strayer DR, Carter WA, Chiba J, Tamura S, Sata T, Kurata T, Hasegawa H. Ichinohe T, et al. Among authors: strayer dr. J Med Virol. 2010 Oct;82(10):1754-61. doi: 10.1002/jmv.21824. J Med Virol. 2010. PMID: 20827774

Cite

Share

10

Cite

Share

Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment.

Liu Q, Ma J, Strayer DR, Mitchell WM, Carter WA, Ma W, Richt JA. Liu Q, et al. Among authors: strayer dr. Expert Rev Anti Infect Ther. 2014 Feb;12(2):165-9. doi: 10.1586/14787210.2014.870885. Epub 2013 Dec 18. Expert Rev Anti Infect Ther. 2014. PMID: 24350808 Free article.

Cite

Share